These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19226462)

  • 21. Spatio-temporal distribution of PfMDR1 polymorphism among uncomplicated Plasmodium falciparum malaria cases along international border of north east India.
    Goomber S; Mishra N; Anvikar A; Yadav CP; Valecha N
    Infect Genet Evol; 2018 Sep; 63():285-290. PubMed ID: 29842979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and molecular monitoring of Plasmodium falciparum resistance to antimalarial drug (artesunate+sulphadoxine-pyrimethamine) in two highly malarious district of Madhya Pradesh, Central India from 2012-2014.
    Mishra S; Bharti PK; Shukla MM; Ali NA; Kashyotia SS; Kumar A; Dhariwal AC; Singh N
    Pathog Glob Health; 2017 Jun; 111(4):186-194. PubMed ID: 28549390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring artemisinin resistance in Plasmodium falciparum: comparison of parasite clearance time by microscopy and real-time PCR and evaluation of mutations in Pfatpase6 gene in Odisha state of India.
    Gupta R; Mishra N; Kumar A; Rana R; Srivastava B; Tyagi PK; Anvikar AR; Valecha N
    Parasitol Res; 2015 Sep; 114(9):3487-96. PubMed ID: 26113507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of mutations associated with antimalarial drugs in Plasmodium falciparum isolates prior to the introduction of sulphadoxine-pyrimethamine as first-line treatment in Iran.
    Zakeri S; Afsharpad M; Raeisi A; Djadid ND
    Malar J; 2007 Nov; 6():148. PubMed ID: 17999755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphisms in Plasmodium falciparum dihydropteroate synthetase and dihydrofolate reductase genes in Nigerian children with uncomplicated malaria using high-resolution melting technique.
    Kayode AT; Ajogbasile FV; Akano K; Uwanibe JN; Oluniyi PE; Eromon PJ; Folarin OA; Sowunmi A; Wirth DF; Happi CT
    Sci Rep; 2021 Jan; 11(1):471. PubMed ID: 33436791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A molecular epidemiologic study of point mutations for pyrimethamine-sulfadoxine resistance of Plasmodium falciparum isolates from Lao PDR.
    Toma H; Imada Y; Vannachone B; Miyagi M; Kobayashi J; Uechi G; Pethuvang R; Manivong K; Phompida S; Sato Y
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):602-4. PubMed ID: 16124424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum isolates from southern Mauritania.
    Eberl KJ; Jelinek T; Aida AO; Peyerl-Hoffmann G; Heuschkel C; el Valy AO; Christophel EM
    Trop Med Int Health; 2001 Oct; 6(10):756-60. PubMed ID: 11679122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria.
    Happi CT; Gbotosho GO; Folarin OA; Sowunmi A; Hudson T; O'Neil M; Milhous W; Wirth DF; Oduola AM
    Antimicrob Agents Chemother; 2009 Mar; 53(3):888-95. PubMed ID: 19075074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disagreement in genotyping results of drug resistance alleles of the Plasmodium falciparum dihydrofolate reductase (Pfdhfr) gene by allele-specific PCR (ASPCR) assays and Sanger sequencing.
    Sharma D; Lather M; Dykes CL; Dang AS; Adak T; Singh OP
    Parasitol Res; 2016 Jan; 115(1):323-8. PubMed ID: 26407876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
    Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of mutations linked to antimalarial resistance in Plasmodium falciparum from Chhattisgarh, Central India: A malaria elimination point of view.
    Patel P; Bharti PK; Bansal D; Ali NA; Raman RK; Mohapatra PK; Sehgal R; Mahanta J; Sultan AA; Singh N
    Sci Rep; 2017 Nov; 7(1):16690. PubMed ID: 29192183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of association between polymorphisms in the pfcoronin and pfk13 genes and the presence of Plasmodium falciparum parasites after treatment with artemisinin derivatives in Senegal.
    Delandre O; Daffe SM; Gendrot M; Diallo MN; Madamet M; Kounta MB; Diop MN; Bercion R; Sow A; Ngom PM; Lo G; Benoit N; Amalvict R; Fonta I; Mosnier J; Diawara S; Wade KA; Fall M; Fall KB; Fall B; Pradines B
    Int J Antimicrob Agents; 2020 Dec; 56(6):106190. PubMed ID: 33045351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania.
    Schönfeld M; Barreto Miranda I; Schunk M; Maduhu I; Maboko L; Hoelscher M; Berens-Riha N; Kitua A; Löscher T
    Malar J; 2007 Jan; 6():2. PubMed ID: 17224049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms in pfdhfr and pfdhps genes after five years of artemisinin combination therapy (ACT) implementation from urban Kolkata, India.
    Chatterjee M; Ganguly S; Saha P; Guha SK; Maji AK
    Infect Genet Evol; 2017 Sep; 53():155-159. PubMed ID: 28533179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré.
    Bonnet M; Roper C; Félix M; Coulibaly L; Kankolongo GM; Guthmann JP
    Malar J; 2007 May; 6():54. PubMed ID: 17477865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased prevalence of pfdhfr and pfdhps mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Jazan Region, Southwestern Saudi Arabia: important implications for malaria treatment policy.
    Madkhali AM; Al-Mekhlafi HM; Atroosh WM; Ghzwani AH; Zain KA; Abdulhaq AA; Ghailan KY; Anwar AA; Eisa ZM
    Malar J; 2020 Dec; 19(1):446. PubMed ID: 33267841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short communication: point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum isolates from Colombia.
    Schmider N; Peyerl-Hoffmann G; Restrepo M; Jelinek T
    Trop Med Int Health; 2003 Feb; 8(2):129-32. PubMed ID: 12581437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detecting adenosine triphosphatase 6 (pfATP6) point mutations that may be associated with Plasmodium falciparum resistance to artemisinin: prevalence at baseline, before policy change in Uganda.
    Kamugisha E; Sendagire H; Kaddumukasa M; Enweji N; Gheysari F; Swedberg G; Kironde F
    Tanzan J Health Res; 2011 Jan; 13(1):40-7. PubMed ID: 24409646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of Plasmodium falciparum Molecular Markers of Antimalarial Drug Resistance in a Residual Malaria Focus Area in Sabah, Malaysia.
    Norahmad NA; Mohd Abd Razak MR; Abdullah NR; Sastu UR; Imwong M; Muniandy PK; Saat MN; Muhammad A; Jelip J; Tikuson M; Yusof N; Rundi C; Mudin RN; Syed Mohamed AF
    PLoS One; 2016; 11(10):e0165515. PubMed ID: 27788228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No Plasmodium falciparum Chloroquine Resistance Transporter and Artemisinin Resistance Mutations, Haiti.
    Vincent JP; Komaki-Yasuda K; Existe AV; Boncy J; Kano S
    Emerg Infect Dis; 2018 Nov; 24(11):2124-2126. PubMed ID: 30334724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.